|
SSR4 expression based on
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.061760E-01 |
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 4 samples. One sample from American Indian patient is not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.567600E-02 |
| Normal-vs-AfricanAmerican |
8.342400E-02 |
| Normal-vs-Asian |
1.469000E-01 |
| Caucasian-vs-AfricanAmerican |
4.277400E-03 |
| Caucasian-vs-Asian |
4.987200E-01 |
| AfricanAmerican-vs-Asian |
3.232600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.528200E-01 |
| Normal-vs-Female |
5.975700E-02 |
| Male-vs-Female |
2.948600E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Note
Four samples from patients aged below 21 are not considered in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.628430E-01 |
| Normal-vs-Age(41-60Yrs) |
5.665900E-02 |
| Normal-vs-Age(61-80Yrs) |
1.697800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.223800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.970600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.555200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.878400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.908200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.307600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.714000E-01 |
|
|
PCPG : Pheochromocytoma and Paraganglioma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Paraganglioma |
8.075500E-02 |
| Normal-vs-Pheochromocytoma |
8.764000E-02 |
| Normal-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
7.316200E-02 |
| Paraganglioma-vs-Pheochromocytoma |
2.62589999999729E-06 |
| Paraganglioma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
8.034000E-01 |
| Pheochromocytoma-vs-Paraganglioma;Extra-adrenal Pheochromocytoma |
4.26899999994568E-06 |
|
|
